Search Ontology:
ChEBI
BAY 73-6691
- Term ID
- CHEBI:231440
- Synonyms
-
- (R)-BAY 73-6691
- (R)-BAY-73-6691
- 1-(2-chlorophenyl)-1,5-dihydro-6-[(2R)-3,3,3-trifluoro-2-methylpropyl]-4H-pyrazolo[3,4-d]pyrimidin-4-one
- 1-(2-chlorophenyl)-6-[(2R)-3,3,3-trifluoro-2-methylpropyl]-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one
- BAY 736691
- BAY-73-6691
- BAY736691
- Definition
- A member of the class of pyrazolopyrimidines that is 4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidine substituted by 2-chlorophenyl, oxo, and (2R)-3,3,3-trifluoro-2-methylpropyl groups at positions 1, 4 and 6, respectively. It is a potent and selective inhibitor of phosphodiesterase 9 (PDE9), currently in pre-clinical development for the treatment of Alzheimer's disease.
- References
-
- cas:794568-92-6
- pubmed:16150925
- pubmed:18674549
- pubmed:22469131
- pubmed:23034509
- pubmed:26346295
- pubmed:27071547
- pubmed:29386424
- pubmed:32826058
- pubmed:38305876
- wikipedia.en:BAY_73-6691
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from BAY 73-6691
Phenotype where environments contain BAY 73-6691
Phenotype modified by environments containing BAY 73-6691
Phenotype affecting BAY 73-6691
Human Disease Model